Hereditary hemorrhagic telangiectasia Clinical Trials in Rochester, Minnesota
2 recruitingRochester, Minnesota
Showing 1–2 of 2 trials
Recruiting
Phase 1Phase 2
A Study to Evaluate ALN-6400 in Healthy Volunteers and Patients With Hereditary Hemorrhagic Telangiectasia (HHT)
Hereditary hemorrhagic telangiectasia
Alnylam Pharmaceuticals120 enrolled16 locationsNCT06659640
Recruiting
Comprehensive HHT Outcomes Registry of the United States (CHORUS)
Gastrointestinal BleedingTelangiectasiaArteriovenous Malformations+4 more
Cure HHT10,000 enrolled16 locationsNCT06259292